Xigris (Zy-gris, drotrecogin alfa), the first drug APPROVED for treating severe sepsis

Lilly is now marketing Xigris (Zy-gris, drotrecogin alfa), the first drug APPROVED for treating severe sepsis.

Until now, the main treatment for severe sepsis was antibiotics.

Xigris is the first drug shown to improve survival in cases of severe septic infections.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote